Strides launches Icosapent Ethyl Acid Soft Gel Capsules in partnership with Amneal

Strides Pharma Science Limited ("Strides") and Amneal Pharmaceuticals, Inc. (NYSE: AMRX) ("Amneal" or the "Company") today announced the addition of Icosapent ethyl acid soft gel capsules, a product referencing VASCEPA®. The product has been in-licensed from Strides, a global pharmaceutical manufacturer, and will be commercialized by Amneal starting in the fourth quarter of 2023.

Icosapent ethyl acid soft gel capsules 0.5g and 1g is an ethyl ester of eicosapentaenoic acid (EPA) that is indicated as an adjunct to diet to reduce triglyceride levels in adult patients with severe (≥ 500 mg/dL) hypertriglyceridemia.

"We are thrilled to announce our partnership with Amneal Pharmaceuticals for Icosapent ethyl acid soft gelatin capsules. This partnership is a testament to our commitment to excellence and the pursuit of cutting-edge solutions. By combining our resources, expertise, and shared passion, we are confident that we will achieve remarkable outcomes that benefit not only our organizations but also our valued customer and stakeholders," said Aditya Kumar, Vice President Business Development, Strides Pharma Science Limited.

"We are on-track to launch over 40 new products in 2023," said Andy Boyer, Executive Vice President, Amneal Generics. "The launch of Icosapent ethyl is another essential medicine that we've added to our portfolio."

Important Safety Information: Adverse effects reported with VASCEPA® include musculoskeletal pain, peripheral edema, constipation, gout, and atrial fibrillation.

Shares of Strides Pharma Science Limited was last trading in BSE at Rs. 502.65 as compared to the previous close of Rs. 486.60. The total number of shares traded during the day was 19254 in over 1144 trades.

The stock hit an intraday high of Rs. 505.10 and intraday low of 488.05. The net turnover during the day was Rs. 9632474.00.

Source : Equity Bulls

Keywords

StridesPharmaScience INE939A01011 AmnealPharmaceuticals AMRX Icosapentethylacid SoftGelCapsules VASCEPA